down arrow

Centene Corp.

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: US15135B1017
USD
38.85
0.04 (0.1%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

38.4239.00

52 Week

25.0766.81
Valuation
Technical
Day's Volume

CASH

995.68 k

Shareholding (Mar 2025)

FII

24.40%

Held by 423 FIIs

DII

32.33%

Held by 96 DIIs

Promoter

0.54%

How big is Centene Corp.?

22-Jun-2025

As of Jun 18, Centene Corp. has a market capitalization of $28.27 billion. As of Dec 24, the company reported shareholder's funds of $26.41 billion and total assets of $83.58 billion.

As of Jun 18, Centene Corp. has a market capitalization of 28,268.27 million, categorizing it as a Large Cap company.<BR><BR>As of Jun 24, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is 3,450.00 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 26,410.00 million and Total Assets at 83,584.00 million.

Read More

What does Centene Corp. do?

22-Jun-2025

Centene Corporation is a healthcare company that offers services primarily to government-sponsored programs for under-insured and uninsured individuals, with a market cap of approximately $28.27 billion. As of March 2025, it reported a net profit of $1.31 billion and key metrics include a P/E ratio of 8.00 and a return on equity of 12.43%.

Overview:<BR>Centene Corporation is a healthcare company that provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals, operating in the Healthcare Services industry with a large-cap market capitalization.<BR><BR>Financial Snapshot:<BR>Net Profit: 1,314 Million (Quarterly Results - Mar 2025)<BR>Market cap: USD 28,268.27 Million (Large Cap)<BR><BR>Key Metrics:<BR>P/E: 8.00<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.04<BR>Return on Equity: 12.43%<BR>Price to Book: 1.01<BR><BR>Contact Details:<BR>Address: 7700 Forsyth Blvd, ST. LOUIS MO: 63105-1807<BR>Tel: 1 314 7254477<BR>Fax: 1 302 6555049<BR>Website: https://www.centene.com/

Read More

Who are in the management team of Centene Corp.?

22-Jun-2025

As of March 2022, Centene Corp.'s management team is led by Mr. Michael Neidorff as Chairman, President, and CEO, with independent directors including Mr. Orlando Ayala, Ms. Jessica Blume, Mr. H. James Dallas, Mr. Robert Ditmore (also Presiding Independent Director), and Mr. Frederick Eppinger.

As of March 2022, the management team of Centene Corp. includes Mr. Michael Neidorff, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the board features several independent directors: Mr. Orlando Ayala, Ms. Jessica Blume, Ms. H. James Dallas, Mr. Robert Ditmore, and Mr. Frederick Eppinger, with Mr. Ditmore also holding the position of Presiding Independent Director.

Read More

Is Centene Corp. overvalued or undervalued?

20-Sep-2025

As of July 25, 2025, Centene Corp. is considered fairly valued but appears overvalued with a P/E ratio of 8 compared to Humana's 37.35, and has underperformed the S&P 500 with a year-to-date return of -46.90%.

As of 25 July 2025, the valuation grade for Centene Corp. has moved from very attractive to fair, indicating a shift in its perceived value. The company appears to be overvalued, given its P/E ratio of 8, which is significantly lower than its peer Humana, Inc., which has a P/E of 37.35, and the industry average is not provided. Additionally, Centene's EV to EBITDA stands at 23.58, while its PEG ratio is a favorable 0.53, suggesting potential growth relative to its price.<BR><BR>In comparison to its peers, Centene Corp. is positioned as fair, while Humana, Inc. is deemed very expensive, highlighting a stark contrast in valuation metrics. The stock has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -46.90% compared to the index's 12.22%, reinforcing the notion that Centene may be overvalued in the current market context.

Read More

Is Centene Corp. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Centene Corp. is in a mildly bearish trend, with mixed technical indicators and significant underperformance compared to the S&P 500, showing a year-to-date return of -46.90% versus the S&P's 12.22%.

As of 9 September 2025, the technical trend for Centene Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, with key indicators such as the MACD showing a mildly bullish signal on the weekly timeframe but bearish on the monthly. The RSI is bullish on the monthly but shows no signal on the weekly. Moving averages are mildly bearish on the daily, and both the KST and OBV indicate bearish trends on the weekly and monthly. <BR><BR>In terms of performance, Centene's returns have significantly underperformed the S&P 500 across multiple periods, with a year-to-date return of -46.90% compared to the S&P 500's 12.22%, and a one-year return of -57.85% versus 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • OPERATING CASH FLOW(Y) Lowest at USD 1,730 MM
  • ROCE(HY) Lowest at 7.5%
  • OPERATING PROFIT(Q) Lowest at USD -402 MM
2

Risky -

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 14,661 Million (Mid Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

7.71%

stock-summary
Price to Book

0.53

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-259 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.6%
0%
35.6%
6 Months
-29.29%
0%
-29.29%
1 Year
-35.0%
0%
-35.0%
2 Years
-47.52%
0%
-47.52%
3 Years
-54.72%
0%
-54.72%
4 Years
-45.32%
0%
-45.32%
5 Years
-39.86%
0%
-39.86%

Centene Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Centene Corp. Stock Hits Day Low of $35.02 Amid Price Pressure

Centene Corp. Stock Hits Day Low of $35.02 Amid Price Pressure

Centene Corp. faced a notable decline in its stock today, reflecting ongoing challenges in the healthcare services sector. Over the past year, the company has experienced significant losses, contrasting sharply with broader market gains. Its financial metrics indicate a conservative leverage approach, yet questions remain about its profitability efficiency.

Read More
Centene Corp. Hits Day High with 12.5% Surge in Strong Intraday Performance

Centene Corp. Hits Day High with 12.5% Surge in Strong Intraday Performance

Centene Corp. has seen notable stock activity, achieving a significant intraday high while outperforming the S&P 500 over the past week and month. Despite recent gains, the company has struggled over the past year, with a substantial decline compared to the broader market. Financial metrics indicate a strong balance sheet.

Read More
Centene Corp. Hits Day High with Strong 5.11% Intraday Surge

Centene Corp. Hits Day High with Strong 5.11% Intraday Surge

Centene Corp. has experienced significant stock activity, gaining 5.11% on October 3, 2025, with an intraday high of USD 38.85. Despite recent gains, the company faces long-term performance challenges, including a one-year decline of 46.28%. It maintains a P/E ratio of 8.00 and a return on equity of 7.71%.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
14.24%
EBIT Growth (5y)
46.06%
EBIT to Interest (avg)
1.53
Debt to EBITDA (avg)
13.55
Net Debt to Equity (avg)
0.66
Sales to Capital Employed (avg)
3.55
Tax Ratio
23.84%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
3.93%
ROE (avg)
12.24%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
1.02
EV to EBIT
NA
EV to EBITDA
23.58
EV to Capital Employed
1.02
EV to Sales
0.17
PEG Ratio
0.53
Dividend Yield
NA
ROCE (Latest)
ROE (Latest)
12.43%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 168 Schemes (42.72%)

Foreign Institutions

Held by 423 Foreign Institutions (24.4%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -119.71% vs 369.29% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "314.00",
          "val2": "315.00",
          "chgp": "-0.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "170.00",
          "val2": "170.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-56.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-259.00",
          "val2": "1,314.00",
          "chgp": "-119.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.20%",
          "val2": "32.90%",
          "chgp": "-4.11%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 22.05% vs 124.54% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,241.00",
          "val2": "1,293.00",
          "chgp": "-4.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "702.00",
          "val2": "725.00",
          "chgp": "-3.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-108.00",
          "val2": "-685.00",
          "chgp": "84.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,294.00",
          "val2": "2,699.00",
          "chgp": "22.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.10%",
          "val2": "23.50%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
314.00
315.00
-0.32%
Interest
170.00
170.00
Exceptional Items
-56.00
0.00
Consolidate Net Profit
-259.00
1,314.00
-119.71%
Operating Profit Margin (Excl OI)
-8.20%
32.90%
-4.11%
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -119.71% vs 369.29% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
1,241.00
1,293.00
-4.02%
Interest
702.00
725.00
-3.17%
Exceptional Items
-108.00
-685.00
84.23%
Consolidate Net Profit
3,294.00
2,699.00
22.05%
Operating Profit Margin (Excl OI)
20.10%
23.50%
-0.34%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 22.05% vs 124.54% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Centene Corp. stock-summary
stock-summary
Centene Corp.
Healthcare Services
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Company Coordinates stock-summary
Company Details
7700 Forsyth Blvd , ST. LOUIS MO : 63105-1807
stock-summary
Tel: 1 314 7254477
stock-summary
https://www.centene.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."